27% Calendar year-Around-Year Earnings Growth, with Ground breaking Medications Accounting for 65.4% of Overall Profits
NANJING, China, Sept. 5, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) introduced its economical outcomes for the 1st half...